The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2015

Filed:

Jul. 13, 2011
Applicants:

Neil D. Brewis, Hauxton, GB;

Benjamin P. Woolven, Bedford, GB;

Steve Holmes, Great Chishill, GB;

Ian M. Tomlinson, Great Shelford, GB;

Jennifer Lee, Cambridge, GB;

Carolyn Enever, Cambridge, GB;

Amrik Basran, Cambridge, GB;

Kate Jones, Cambridge, GB;

Ruud DE Wildt, Cambridge, GB;

Stanislas Blein, Briancon, FR;

Inventors:

Neil D. Brewis, Hauxton, GB;

Benjamin P. Woolven, Bedford, GB;

Steve Holmes, Great Chishill, GB;

Ian M. Tomlinson, Great Shelford, GB;

Jennifer Lee, Cambridge, GB;

Carolyn Enever, Cambridge, GB;

Amrik Basran, Cambridge, GB;

Kate Jones, Cambridge, GB;

Ruud de Wildt, Cambridge, GB;

Stanislas Blein, Briancon, FR;

Assignee:

Domantis Limited, Brentford, Middlesex, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/24 (2006.01); A61K 47/48 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01); C07K 16/40 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/241 (2013.01); A61K 47/48215 (2013.01); A61K 2039/505 (2013.01); C07K 16/18 (2013.01); C07K 16/2866 (2013.01); C07K 16/2878 (2013.01); C07K 16/40 (2013.01); C07K 2317/21 (2013.01); C07K 2317/31 (2013.01); C07K 2317/569 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01);
Abstract

The invention provides methods for treating inflammatory diseases (e.g., chronic inflammatory diseases) comprising administering an antagonist of Tumor Necrosis Factor Receptor 1. The invention also provides ligands that contain an immunoglobulin single variable domain (domain antibody, dAb) monomer that binds Tumor Necrosis Factor Receptor 1, and methods of using the ligands. Also provided are nucleic acids encoding the ligands, recombinant host cells and methods for preparing the ligands.


Find Patent Forward Citations

Loading…